Target intelligence / Profile preview

ALMS1 intronic transcript 1 (ALMS1-IT1)

Target
ALMS1-IT1
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

ALMS1 intronic transcript 1 (ALMS1-IT1) is a long non-coding RNA that does not code for a protein and is derived from an intronic region of the ALMS1 gene. It has been identified as playing a regulatory role in several cancers, including colorectal cancer, colon adenocarcinoma, lung adenocarcinoma, and head and neck squamous cell carcinoma. Elevated expression of ALMS1-IT1 in cancer tissues has been associated with a worse prognosis. Functional studies suggest that ALMS1-IT1 can modulate ferroptosis (an iron-dependent form of cell death) and immune evasion, potentially through activation of pathways such as STAT3. Bioinformatic analyses indicate ALMS1-IT1 influences nucleosome and chromatin assembly, and is associated with epigenetic modifications such as DNA and histone methylation. It interacts with numerous microRNAs and RNA binding proteins and is significantly correlated with immune cell infiltration, particularly with NK cells and dendritic cells in tumor microenvironments. Due to its association with tumor progression and patient survival, ALMS1-IT1 is proposed as a novel prognostic biomarker in multiple malignancies[2][1][4][6].

Other names
ALMS1 intronic transcript 1 (non-protein coding)lncRNA ALMS1-IT1
02

Biological functions

Regulation of tumor progressionRegulation of immune evasionModulation of ferroptosisControl of nucleosome/chromatin assemblyRegulation of DNA methylation and histone methylation
03

Disease associations

CancerColorectal cancerColon adenocarcinomaLung adenocarcinomaHead and neck squamous cell carcinomaNeuroinflammatory diseaseOther
04

Biomarkers

Prognostic biomarker for colon adenocarcinomaPrognostic biomarker for head and neck squamous cell carcinoma

Beyond the preview

Go deeper on ALMS1 intronic transcript 1 (ALMS1-IT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALMS1 intronic transcript 1 (ALMS1-IT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call